Power, punishment, and legacy are colliding in a way that has baseball fans asking a simple question: who really gets forgiven, and who gets left out forever? And this is the part most people miss: the debate over Alex Rodriguez and Bud Selig is not just about stats or scandal—it’s about who gets to walk into Cooperstown with a clean narrative and who stays on the outside as the face of an era’s sins.
Alex Rodriguez is no longer just upset about being kept out of the Hall of Fame; he is openly challenging how the gatekeepers decide who deserves a plaque. He sees a clear double standard in the way some figures from the steroid era are honored while others are shunned, even though they were all part of the same story. That tension has turned his personal disappointment into a broader, very public criticism of the Hall of Fame system.
Selig in, stars out
Former MLB commissioner Bud Selig was enshrined in the Hall of Fame in 2017, even though many of the era’s biggest on-field stars are still on the outside looking in because of their connections to performance-enhancing drugs. To Rodriguez, it is striking that the man who oversaw the league during the height of the PED era has a bronze plaque, while players whose careers defined that time remain blacklisted.
Rodriguez discussed this issue during a conversation with Stephen A. Smith on Smith’s SiriusXM show, where the topic of PEDs and Hall of Fame voting came up directly. Smith noted that he could understand why someone like Barry Bonds might have felt tempted to use steroids after watching Mark McGwire and Sammy Sosa become celebrated superstars during the 1998 home run chase.
Calling out ‘hypocrisy’
Rodriguez pushed back on the idea that players alone should bear the blame, reminding Smith that all of those legendary performances took place under Selig’s leadership as commissioner. He argued that it is hard to ignore the contradiction: iconic sluggers tied to PEDs cannot get into the Hall, yet the commissioner who benefited from that offensive explosion has already been honored there.
That led him to use a word that instantly raises eyebrows: hypocrisy. In his view, if the Hall of Fame is going to punish players for the steroid era, then rewarding the person who presided over that same era sends a mixed moral message. Do you think he has a point, or is he overlooking the difference between a commissioner’s role and a player’s personal choices?
A-Rod’s fading Hall chances
Rodriguez is now appearing on the Hall of Fame ballot for the fifth time, but he has not yet reached even 40 percent support from voters. Since a candidate needs 75 percent to be elected, his statistical achievements alone are unlikely to overcome voter resistance rooted in his PED history.
He is not alone in this predicament. Barry Bonds, Roger Clemens, Mark McGwire, and Sammy Sosa all put up historic, video-game-level numbers, but their links to performance-enhancing drugs have left their Hall chances dwindling as their time on the ballot shrinks. But here’s where it gets controversial: should the Hall of Fame be a museum that tells the full, messy truth about baseball history, or a reward only for those considered “clean” by today’s standards?
Different paths into Cooperstown
Part of the confusion comes from the way different people are even evaluated for induction. Selig was not elected through the writers’ ballot at all; he went in via the 16-person Today’s Game Era Committee, which focuses on figures like executives, managers, and other contributors rather than current-era players.
By contrast, players such as Rodriguez and Bonds must face the Baseball Writers’ Association of America (BBWAA), which votes using its own standards and unwritten rules shaped by decades of tradition and individual bias. That split creates a system where commissioners and players from the same era are judged in fundamentally different ways, even though their legacies are intertwined.
The steroid-era backdrop
Selig’s tenure as commissioner stretched from 1992 to 2015, covering the most notorious years of PED use in Major League Baseball. That includes the McGwire–Sosa home run race in 1998 and Bonds’ record-setting 73-homer season in 2001, events that helped revive fan interest and boosted the sport’s popularity.
During much of that period, MLB did not have strong, enforceable rules against performance-enhancing drugs, and serious, league-wide testing and penalties did not begin until the 2004 Joint Drug Agreement. Critics argue that the league was slow to act because the offensive fireworks were good for business, while players now carry the bulk of the blame in the historical record. Is it fair that the era’s marketing benefits went to the league and owners, while the reputational cost now falls primarily on individual stars?
Rodriguez on therapy and mistakes
Rodriguez also used the conversation to look inward, talking about how therapy changed his life and how he has tried to own his mistakes rather than run from them. He explained that he began therapy before his year-long suspension and has continued it, emphasizing to younger fans that his story should not just be about home runs and awards but also about accountability and growth.
He framed his suspension as a turning point, not just a punishment. By sharing the darker parts of his journey, he aims to give a more complete picture of what can happen when ambition, pressure, and ego go unchecked in a high-profile career. And this is the part most people miss: his public vulnerability is also a strategic attempt to reshape how history remembers him.
Ego, Jeter, and the Yankees
While promoting his HBO docuseries “Alex vs. A-Rod,” Rodriguez revisited how his ego and lack of self-awareness affected his time with the New York Yankees. He talked about how understanding his role in the clubhouse and in the wider baseball world did not come easily and often came only after public missteps.
He highlighted his long relationship with Derek Jeter, whom he first met as a 17-year-old and still describes as an exceptionally grounded, almost flawless person. Rodriguez contrasted Jeter’s seemingly spotless image with his own long list of errors, saying that he has learned to accept and even love himself, flaws and all—the good, the bad, and the ugly.
A legacy shaped by conflict
For Rodriguez, the Hall of Fame debate is really a debate over how the entire steroid era should be remembered. It is not only about his numbers but also about the combination of PED scandals, clashing personalities, and very public battles with baseball’s power structure.
That includes his infamous 2013 showdown with Selig and MLB, when he was hit with a 162-game suspension, the longest non-lifetime ban in league history. He responded by suing the league before eventually dropping the case, turning the episode into one of the most dramatic confrontations between a star player and baseball’s leadership in modern times.
Your turn: hypocrisy or accountability?
At the heart of all this sits a thorny question: can the Hall of Fame credibly celebrate a commissioner who presided over the steroid era while shutting out many of the players who made that era unforgettable? Or is it reasonable to argue that players ultimately chose to break the rules, even in a lax environment, and should therefore bear a heavier cost than the executives above them?
So what do you think: is Rodriguez right to call the situation hypocritical, or is he simply trying to reframe his own legacy after the fact? Should Cooperstown be a place that tells the full story of baseball’s steroid era—including flawed legends—or should it keep drawing a hard line against anyone tied to PEDs while still honoring the officials who oversaw that time? Share where you stand—does this system feel fair to you, or does it need a complete rethink?
